Guest guest Posted May 1, 2005 Report Share Posted May 1, 2005 Jami and Kaylene, After I finally quit looking, I found the research material that I was looking for that pertained to FMS and Xyrem....doesn't it always work that way? Dr. Scharf, Director of the Tri-State Sleep Disorders Clinic in Cincinnati, OH, kicked off the research. He was using Xyrem for narcolepsy patients, and found that 2 of them who had FMS showed dramatic improvement in their pain and fatigue when on Xyrem. His first study did not prove conclusively that it helped, but did spark questions, so a second, more controlled study was planned. The results of this study, which were published in May of 2003, showed impressive results. There were overall improvements in pain, cognition, and fatigue. The findings occurred in association with several sleep parameters, including increased slow alpha wave sleep. Some of the improvements that occurred were as follows -3 of 4 pain ratings were lowered by 30% and all 3 fatigue ratings were lowered by 32% -time to fall asleep was less than 8 minutes -slow wave sleep was increased 7% of the time -There was a reduction in alpha-EEG intrustion from 37% to 26% correlated with patient reported improvements in pain and fatigue -there were no withdrawal symptoms or " rebound insomnia " symptoms when the drug was stopped -there was no loss of efficacy even after 40 months on the drug -Xyrem is metabolized by the Krebs cycle (the same digestive cycle that breaks down food), so it is not likely to interfere with other meds. -Virtually everyone responds to it. -Many of Scharf's patients returned to their former function, and got their lived back on track. Now Xyrem is in a controlled research environment, with sleep specialists testing it on people with severe sleep disorders, both those with and without FMS, as we all know. The only fear is that the drug will again saturate the market, and that there will be another surge in it's sales on the black market as the " date rape " drug. Hopefully, with its carefully controlled prescribing by Orphan, and good screening processes in place, people's nightmares with sleep problems will be a thing of the past. Another interesting piece of information...the NIH was funding a study by Northwestern University, and a company called SloWave, to develop a drug that mimics GHB, the active component in Xyrem, in a long acting pill with two peak releases. This drug would not be the agent of abuse that Xyrem could potentially be, easing doctors, and patients, fears of using it. I hope this is the information you were looking for regarding Xyrem and FMS, and it helps! Sorry it took me so long to come up with it! Jen Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.